Affiliation: Karolinska Institutet
- Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomographyMirjam Talvik
Karolinska Institute, Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital R4, SE 171 76 Stockholm, Sweden
Psychiatry Res 148:165-73. 2006....
- Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457Mirjam Talvik
Department of Clinical Neuroscience, Psychiatry Section, Karolinska Psychiatric Centre, Karolinska Hospital, S 171 76 Stockholm, Sweden
Int J Neuropsychopharmacol 6:361-70. 2003..The preliminary finding of low thalamic D2/D3 BP in patients strengthens the hypothesis that the thalamus is a key region in the pathophysiology of schizophrenia...
- A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentrationMirjam Talvik
Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institute, S 171 76 Stockholm, Sweden
Psychopharmacology (Berl) 175:148-53. 2004..Positron emission tomography (PET) studies have suggested an optimal interval in central dopamine D2 receptor occupancy of between 65 and 80%...